Cardinal Health (NYSE:CAH) CEO Sells $5,386,586.04 in Stock

Key Points

• Cardinal Health CEO Jason Hollar sold 35,901 shares of the company's stock for approximately $5.39 million, resulting in a 15.22% decrease in his holdings.
• The company reported a net revenue of $60.16 billion for the last quarter, slightly below the consensus estimate, while earnings per share (EPS) beat expectations at $2.08.
• Cardinal Health declared a quarterly dividend of $0.5107 per share, with an annualized yield of 1.3%, to be paid on October 15th.

Cardinal Health, Inc. (NYSE:CAH - Get Free Report) CEO Jason Hollar sold 35,901 shares of the company's stock in a transaction on Wednesday, August 20th. The shares were sold at an average price of $150.04, for a total transaction of $5,386,586.04. Following the completion of the sale, the chief executive officer owned 200,000 shares of the company's stock, valued at approximately $30,008,000. This trade represents a 15.22% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.

Cardinal Health Price Performance

CAH stock opened at $151.7360 on Friday. The company has a fifty day moving average price of $159.28 and a 200 day moving average price of $145.17. Cardinal Health, Inc. has a 12 month low of $106.54 and a 12 month high of $168.44. The company has a market cap of $36.23 billion, a price-to-earnings ratio of 23.52, a price-to-earnings-growth ratio of 1.29 and a beta of 0.67.

Cardinal Health (NYSE:CAH - Get Free Report) last released its quarterly earnings results on Tuesday, August 12th. The company reported $2.08 EPS for the quarter, beating the consensus estimate of $2.03 by $0.05. Cardinal Health had a net margin of 0.70% and a negative return on equity of 74.45%. The firm had revenue of $60.16 billion during the quarter, compared to the consensus estimate of $60.91 billion. During the same quarter in the prior year, the firm earned $1.84 EPS. Cardinal Health's revenue for the quarter was up .5% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. As a group, analysts anticipate that Cardinal Health, Inc. will post 7.95 earnings per share for the current year.

Cardinal Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 15th. Shareholders of record on Wednesday, October 1st will be given a dividend of $0.5107 per share. The ex-dividend date is Wednesday, October 1st. This represents a $2.04 dividend on an annualized basis and a yield of 1.3%. Cardinal Health's dividend payout ratio is presently 31.63%.

Hedge Funds Weigh In On Cardinal Health

Large investors have recently made changes to their positions in the stock. Principal Financial Group Inc. increased its holdings in shares of Cardinal Health by 5.3% in the 1st quarter. Principal Financial Group Inc. now owns 315,817 shares of the company's stock valued at $43,510,000 after purchasing an additional 15,956 shares in the last quarter. Kingswood Wealth Advisors LLC boosted its stake in shares of Cardinal Health by 17.2% during the 1st quarter. Kingswood Wealth Advisors LLC now owns 3,119 shares of the company's stock worth $429,000 after purchasing an additional 457 shares during the last quarter. Assenagon Asset Management S.A. boosted its stake in shares of Cardinal Health by 25.8% during the 1st quarter. Assenagon Asset Management S.A. now owns 13,147 shares of the company's stock worth $1,811,000 after purchasing an additional 2,694 shares during the last quarter. Golden State Wealth Management LLC boosted its stake in shares of Cardinal Health by 569.5% during the 1st quarter. Golden State Wealth Management LLC now owns 395 shares of the company's stock worth $54,000 after purchasing an additional 336 shares during the last quarter. Finally, North Capital Inc. acquired a new stake in shares of Cardinal Health during the 1st quarter worth about $83,000. Hedge funds and other institutional investors own 87.17% of the company's stock.

Wall Street Analysts Forecast Growth

A number of equities analysts have commented on CAH shares. Citigroup restated a "neutral" rating and set a $170.00 price objective (up previously from $157.00) on shares of Cardinal Health in a research report on Friday, June 13th. Wall Street Zen downgraded shares of Cardinal Health from a "strong-buy" rating to a "buy" rating in a research report on Saturday, August 2nd. Robert W. Baird upped their price objective on shares of Cardinal Health from $197.00 to $203.00 and gave the stock an "outperform" rating in a research report on Wednesday, August 13th. UBS Group restated a "buy" rating on shares of Cardinal Health in a research report on Tuesday, August 12th. Finally, Jefferies Financial Group set a $150.00 price objective on shares of Cardinal Health in a research report on Tuesday, August 12th. Twelve equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company's stock. According to data from MarketBeat.com, Cardinal Health presently has a consensus rating of "Moderate Buy" and a consensus price target of $163.20.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.